Novel Strategies for Anterior Segment Ocular Drug Delivery

Por Cholkar, Kishore, Patel, Sulabh P., Vadlapudi, Aswani Dutt, Mitra, Ashim K.
Publicado em 2013

SYSTEMATIC EVALUATION OF DRUG-DISEASE RELATIONSHIPS TO IDENTIFY LEADS FOR NOVEL DRUG USES

Por Chiang, Annie P., Butte, Atul J.
Publicado em 2009

Novel drug targets based on metallobiology of Alzheimer’s disease

Por Bandyopadhyay, Sanghamitra, Huang, Xudong, Lahiri, Debomoy K, Rogers, Jack T
Publicado no Expert Opin Ther Targets (2010)

Novel botanical drug DA-9803 prevents deficits in Alzheimer’s mouse models

Por Pagnier, Guillaume J., Kastanenka, Ksenia V., Sohn, Miwon, Choi, Sangzin, Choi, Song-hyen, Soh, HyeYeon, Bacskai, Brian J.
Publicado no Alzheimers Res Ther (2018)

Epigenetic targets for novel therapies of lung diseases

Por Comer, Brian S., Ba, Mariam, Singer, Cherie A., Gerthoffer, William T.
Publicado no Pharmacol Ther (2014)

Lifitegrast: a novel drug for patients with dry eye disease

Por Haber, Stacy L., Benson, Vera, Buckway, Casey J., Gonzales, Jennifer M., Romanet, David, Scholes, Brittany
Publicado no Ther Adv Ophthalmol (2019)

Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer

Por May FEB
Publicado em 2014-05-01

Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M(4) Muscarinic Receptor as a Novel Therapeutic Target

Por Gogliotti, Rocco G., Fisher, Nicole M., Stansley, Branden J., Jones, Carrie K., Lindsley, Craig W., Conn, P. Jeffrey, Niswender, Colleen M.
Publicado no J Pharmacol Exp Ther (2018)

A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction

Por Hay, Meredith, Polt, Robin, Heien, Michael L., Vanderah, Todd W., Largent-Milnes, Tally M., Rodgers, Kathleen, Falk, Torsten, Bartlett, Mitchell J., Doyle, Kristian P., Konhilas, John P.
Publicado no J Pharmacol Exp Ther (2019)

Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review

Por Csermely, Peter, Korcsmáros, Tamás, Kiss, Huba J.M., London, Gábor, Nussinov, Ruth
Publicado em 2013

THER-28. A CK1α ACTIVATOR PENETRATES THE BRAIN, AND SHOWS EFFICACY AGAINST DRUG-RESISTANT METASTATIC MEDULLOBLASTOMA

Por Rodriguez, Jezabel, Li, Bin, Long, Jun, Shen, Chen, Yang, Fan, Orthon, Darren, Collins, Sara, Kasahara, Noriyuki, Ayad, Nagi, McCrea, Heather, Roussel, Martine, Weiss, William, Capobianco, Anthony, Robbins, David
Publicado no Neuro Oncol (2019)

Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer’s disease

Por Tsuji, Shingo, Hase, Takeshi, Yachie-Kinoshita, Ayako, Nishino, Taiko, Ghosh, Samik, Kikuchi, Masataka, Shimokawa, Kazuro, Aburatani, Hiroyuki, Kitano, Hiroaki, Tanaka, Hiroshi
Publicado no Alzheimers Res Ther (2021)

Novel antibody–drug conjugates for triple negative breast cancer

Por Nagayama, Aiko, Vidula, Neelima, Ellisen, Leif, Bardia, Aditya
Publicado no Ther Adv Med Oncol (2020)

Commentary: A Novel Disease-Drug Database Demonstrating Applicability for Pharmacogenomic-Based Prescribing

Por Whirl-Carrillo, M., Sangkuhl, K., Gong, L., Klein, T.E.
Publicado no Clin Pharmacol Ther (2016)

A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism

Por Daugherty, Daniel, Goldberg, Joshua, Fischer, Wolfgang, Dargusch, Richard, Maher, Pamela, Schubert, David
Publicado no Alzheimers Res Ther (2017)

Self-Nanoemulsifying Drug Delivery System of Genkwanin: A Novel Approach for Anti-Colitis-Associated Colorectal Cancer

Por Yin, Hua-Feng, Yin, Chun-Ming, Ouyang, Ting, Sun, Shu-Ding, Chen, Wei-Guo, Yang, Xiao-Lin, He, Xin, Zhang, Chun-Feng
Publicado no Drug Des Devel Ther (2021)

VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs

Por Schub, David, Assmann, Gunter, Sester, Urban, Sester, Martina, Schmidt, Tina
Publicado no Arthritis Res Ther (2018)

Apremilast: A Novel PDE4 Inhibitor in the Treatment of Autoimmune and Inflammatory Diseases

Por Schett, Georg, Sloan, Victor S., Stevens, Randall M., Schafer, Peter
Publicado em 2010

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Por Öhrfelt, Annika, Brinkmalm, Ann, Dumurgier, Julien, Brinkmalm, Gunnar, Hansson, Oskar, Zetterberg, Henrik, Bouaziz-Amar, Elodie, Hugon, Jacques, Paquet, Claire, Blennow, Kaj
Publicado no Alzheimers Res Ther (2016)

Exploring prospects of novel drugs for tuberculosis

Por Janssen, Saskia, Jayachandran, Rajesh, Khathi, Lulama, Zinsstag, Jakob, Grobusch, Martin P, Pieters, Jean
Publicado em 2012